The neuroprotective effect of 2-oxoglutarate in the experimental ischemia of hippocampus

Journal of Physiology and Pharmacology

Volumn 62, Issue 2, 2011, Pages 239-246

  Kovalenko, T N ^a   Ushakova, G A ^b   Osadchenko, I ^a   Skibo, G G ^a   Pierzynowski, S G ^c,d  

^a BOGOMOLETZ INSTITUTE OF PHYSIOLOGY   (Ukraine)

^b OLES HONCHAR DNIPRO NATIONAL UNIVERSITY   (Ukraine)

^c LUND UNIVERSITY   (Sweden)

^d IMW   (Poland)

Author keywords

2 oxoglutarate; Brain; Glial fibrillary acid protein (gfap); Hippocampus; Ischemia; Neural cell adhesion molecule (ncam); Neuronal specific nuclear protein (neun); S100 calcium binding protein b (s100b)

Indexed keywords

2 OXOGLUTARIC ACID; GLIAL FIBRILLARY ACIDIC PROTEIN; NERVE CELL ADHESION MOLECULE; NEURON SPECIFIC NUCLEAR PROTEIN; PROTEIN S100B;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; ASTROCYTOSIS; BRAIN ISCHEMIA; CAROTID ARTERY OBSTRUCTION; CELL SURVIVAL; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; GERBIL; GLIA CELL; HIPPOCAMPAL CA1 REGION; NERVE CELL NECROSIS; NERVE CELL PLASTICITY; NEUROPROTECTION; NONHUMAN; PYRAMIDAL NERVE CELL; TREATMENT DURATION;

ADMINISTRATION, ORAL; ANIMALS; BRAIN ISCHEMIA; CA1 REGION, HIPPOCAMPAL; GERBILLINAE; KETOGLUTARIC ACIDS; NEUROPROTECTIVE AGENTS; RANDOM ALLOCATION;

EID: 79959342918     PISSN: 08675910     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (53)

1. May M, McCarron P, Stansfeld S, Ben-Shlomo Y, Gallacher J, Yarnell J. Does psychological distress predict the risk of ischemic stroke and transient ischemic attack? The Caerphilly Study. Stroke 2002; 33: 7-12.
2. Redgrave JN, Coutts SB, Schulz UG, Briley D, Rothwell PM. Systematic review of associations between the presence 244 of acute ischemic lesions on diffusion-weighted imaging and clinical predictors of early stroke risk after transient ischemic attack. Stroke 2007; 38: 1482-1488.
3. Sheline CT, Wei L. Free radical-mediated neurotoxicity may be caused by inhibition of mitochondrial dehydrogenases in vitro and in vivo. Neuroscience 2006; 140: 235-246.
4. Hossmann KA. Pathophysiology and therapy of experimental stroke. Cell Mol Neurobiol 2006; 26: 1057-1083.
5. Hossmann KA. Pathophysiological basis of translational stroke research. Folia Neuropathol 2009; 47: 213-227.
6. Bunik VI, Degtyarev D. Structure-function relationships in the 2-oxo acid dehydrogenase family: substrate-specific signatures and functional predictions for the 2-oxoglutarate dehydrogenase-like proteins. Proteins 2008; 71: 874-890.
7. Trofimova L, Lovat M, Groznaya A, et al. Behavioral impact of the regulation of the brain 2-oxoglutarate dehydrogenase complex by synthetic phosphonate analog of 2-oxoglutarate: implications into the role of the complex in neurodegenerative diseases. Int J Alzheimers Dis 2010; 2010: 749061.
8. Desagher S, Glowinski J, Premont J. Pyruvate protects neurons against hydrogen peroxide-induced toxicity. J Neurosci 1997; 17: 9060-9067.
9. Harrison AP, Pierzynowski SG. Biological effects of 2- oxoglutarate with particular emphasis on the regulation of protein, mineral and lipid absorption/metabolism, muscle performance, kidney function, bone formation and cancerogenesis, all viewed from a healthy ageing perspective state of the art. J Physiol Pharmacol 2008; 59: 91-106.
10. Janac B, Selakovic V, Radenovic L. Temporal patterns of motor behavioural improvements by MK-801 in Mongolian gerbils submitted to different duration of global cerebral ischemia. Behav Brain Res 2008; 194: 72-78.
11. Ji L, Nazarali AJ, Paterson PG. Protein-energy malnutrition increases activation of the transcription factor, nuclear factor kappaB, in the gerbil hippocampus following global ischemia. J Nutr Biochem 2008; 19: 770-777.
12. Ushakova G, Fed'kiv O, Prykhod'ko O, Pierzynowski S, Kruszewska D. The effect of long-term lactobacilli (lactic acid bacteria) enteral treatment on the central nervous system of growing rats. J Nutr Biochem 2009; 20: 677-684.
13. Ushakova GA, Nikonenko IR, Nikonenko AG, Skibo GG. Extracellular matrix heparin induces alteration of the cell adhesion during brain development. Neurochem Int 2002; 40: 277-283.
14. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976; 72: 248-254.
15. Kirino T, Tamura A, Sano K. Selective vulnerability of the hippocampus to ischemia - reversible and irreversible types of ischemic cell damage. Progress in Brain Res 1985; 63: 39-58.
16. Gascon E, Vutskits L, Kiss JZ. Polysialic acid-neural cell adhesion molecule in brain plasticity: from synapses to integration of new neurons. Brain Res Rev 2007; 56: 101-118.
17. Katidou M, Vidaki M, Strigini M, Karagogeos D. The immunoglobulin superfamily of neuronal cell adhesion molecules: lessons from animal models and correlation with human disease. Biotechnol J 2008; 3: 1564-1580.
18. Zhang Y, Yeh J, Richardson PM, Bo X. Cell adhesion molecules of the immunoglobulin superfamily in axonal regeneration and neural repair. Restor Neurol Neurosci 2008; 26: 81-96.
19. Schmid RS, Maness PF. L1 and NCAM adhesion molecules as signaling coreceptors in neuronal migration and process outgrowth. Curr Opin Neurobiol 2008; 18: 245-250.
20. Gascon E, Vutskits L, Kiss JZ. The role of PSA-NCAM in adult neurogenesis. Adv Exp Med Biol 2010; 663: 127-136.
21. Dragun P, Makarewicz D, Wojcik L, Ziemka-Nalecz M, Slomka M, Zalewska T. Matrix metalloproteinases activity during the evolution of hypoxic-ischemic brain damage in the immature rat. The effect of 1-methylnicotinamide (MNA). J Physiol Pharmacol 2008; 59: 441-455.
22. Sokolowska B, Jozwik A, Niebroj-Dobosz I, Janik P, Kwiecinski H. Evaluation of matrix metalloproteinases in serum of patients with amyotrophic lateral sclerosis with pattern recognition methods. J Physiol Pharmacol 2009; (60 Suppl 5): 117-120.
23. Wright JW, Harding JW. Contributions of matrix metalloproteinases to neural plasticity, habituation, associative learning and drug addiction. Neural Plast 2009; 2009: 579382.
24. Yamashima T, Popivanova BK, Guo J, Kotani S, Wakayama T, Iseki S. Implication of "Down syndrome cell adhesion molecule" in the hippocampal neurogenesis of ischemic monkeys. Hippocampus 2006; 16: 924-935.
25. Strosznajder RP, Walski M. Effects 3-aminobenzamide on ultrastructure of hippocampal CA1 layer after global ischemia in gerbils. J Physiol Pharmacol 2004; 55(Suppl 3): 127-133.
26. Broughton BR, Reutens DC, Sobey CG. Apoptotic mechanisms after cerebral ischemia. Stroke 2009; 40: 331-339.
27. Murphy E, Steenbergen C. Ion transport and energetics during cell death and protection. Physiology (Bethesda) 2008; 23: 115-123.
28. Strosznajder RP, Jesko H, Banasik M, Tanaka S. Effects of p53 inhibitor on survival and death of cells subjected to oxidative stress. J Physiol Pharmacol 2005; 56(Suppl 4): 215-221.
29. Khosravani H, Altier C, Simms B, et al. Gating effects of mutations in the Cav3.2 T-type calcium channel associated with childhood absence epilepsy. J Biol Chem 2004; 279: 9681-9684.
30. Mozaffari MS, Patel C, Schaffer SW. Mechanisms underlying afterload-induced exacerbation of myocardial infarct size: role of T-type Ca2+ channel. Hypertension 2006; 47: 912-919.
31. Edvinsson L. Calcitonin gene-related peptide (CGRP) in cerebrovascular disease. ScientificWorldJournal 2002; 2: 1484-1490.
32. Tuttolomondo A, Di Sciacca R, Di Raimondo D, Renda C, Pinto A, Licata G. Inflammation as a therapeutic target in acute ischemic stroke treatment. Curr Top Med Chem 2009; 9: 1240-1260.
33. Bednarczyk P. Potassium channels in brain mitochondria. Acta Biochim Pol 2009; 56: 385-392.
34. Ouyang YB, Voloboueva LA, Xu LJ, Giffard RG. Selective dysfunction of hippocampal CA1 astrocytes contributes to delayed neuronal damage after transient forebrain ischemia. J Neurosci 2007; 27: 4253-4260.
35. Yu AC, Lee YL, Fu WY, Eng LF. Gene expression in astrocytes during and after ischemia. Prog Brain Res 1995; 105: 245-253.
36. Sen J, Belli A. S100B in neuropathologic states: the CRP of the brain? J Neurosci Res 2007; 85: 1373-1380.
37. Kaur C, Foulds WS, Ling EA. Hypoxia-ischemia and retinal ganglion cell damage. Clin Ophthalmol 2008; 2: 879-889.
38. Ikura M, Osawa M, Ames JB. The role of calcium-binding proteins in the control of transcription: structure to function. Bioessays 2002; 24: 625-636.
39. Garbuglia M, Verzini M, Sorci G, et al. The calciummodulated proteins, S100A1 and S100B, as potential regulators of the dynamics of type III intermediate filaments. Braz J Med Biol Res 1999; 32: 1177-1185.
40. Pekny M, Wilhelmsson U, Bogestal YR, Pekna M. The role of astrocytes and complement system in neural plasticity. Int Rev Neurobiol 2007; 82: 95-111.
41. Karwacki Z, Kowianski P, Dziewiatkowski J, et al. The influence of sevoflurane on the reactivity of astrocytes in the course of the experimental intracerebral haemorrhage in rat. J Physiol Pharmacol 2005; 56: 455-469.
42. Bunik VI, Kabysheva MS, Klimuk EI, Storozhevykh TP, Pinelis VG. Phosphono analogues of 2-oxoglutarate protect cerebellar granule neurons upon glutamate excitotoxicity. Ann N Y Acad Sci 2009; 1171: 521-529.
43. Kabysheva MS, Storozhevykh TP, Pinelis VG, Bunik VI. Synthetic regulators of the 2-oxoglutarate oxidative decarboxylation alleviate the glutamate excitotoxicity in cerebellar granule neurons. Biochem Pharmacol 2009; 77: 1531-1540.
44. Hosseini F, Naseri MK, Badavi M, Ghaffari MA, Shahbazian H, Rashidi I. Protective effect of beta carotene pretreatment on renal ischemia/reperfusion injury in rat. Pak J Biol Sci 2009; 12: 1140-1145.
45. Lerman LO, Textor SC, Grande JP. Mechanisms of tissue injury in renal artery stenosis: ischemia and beyond. Prog Cardiovasc Dis 2009; 52: 196-203.
46. Suyani E, Derici UB, Sahin T, et al. Effects of everolimus on cytokines, oxidative stress, and renal histology in ischemia-reperfusion injury of the kidney. Ren Fail 2009; 31: 698-703.
47. Choi K, Kim J, Kim GW, Choi C. Oxidative stress-induced necrotic cell death via mitochondira-dependent burst of reactive oxygen species. Curr Neurovasc Res 2009; 6: 213-222.
48. Dakshayani KB, Subramanian P. Alpha-ketoglutarate modulates the circadian patterns of lipid peroxidation and antioxidant status during N-nitrosodiethylamine-induced hepatocarcinogenesis in rats. J Med Food 2006; 9: 90-97.
49. Tulsawani R, Bhattacharya R. Effect of alpha-ketoglutarate on cyanide-induced biochemical alterations in rat brain and liver. Biomed Environ Sci 2006; 19: 61-66.
50. Matsumoto K, Imagawa S, Obara N, et al. 2-oxoglutarate downregulates expression of vascular endothelial growth factor and erythropoietin through decreasing hypoxiainducible factor-1-alpha and inhibits angiogenesis. J Cell Physiol 2006; 209: 333-340.
51. Bruegge K, Jelkmann W, Metzen E. Hydroxylation of hypoxia-inducible transcription factors and chemical compounds targeting the HIF-alpha hydroxylases. Curr Med Chem 2007; 14: 1853-1862.
52. Madri JA. Modeling the neurovascular niche: implications for recovery from CNS injury. J Physiol Pharmacol 2009; 60(Suppl 4): 95-104.
53. Bunik VI, Fernie AR. Metabolic control exerted by the 2- oxoglutarate dehydrogenase reaction: a cross-kingdom comparison of the crossroad between energy production and nitrogen assimilation. Biochem J 2009; 422: 405-421.